Literature DB >> 1386318

Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes.

C Fargeas1, C Y Wu, T Nakajima, D Cox, T Nutman, G Delespesse.   

Abstract

(TGF)-beta is a pluripotent cytokine exerting differential effects on distinct components of the immune response. The present report, based on lymphokine determination in culture supernatants and Northern blot analysis of lymphokine mRNA, demonstrates that TGF-beta 2 markedly inhibits interleukin (IL)-4 and IL-5 synthesis by polyclonally activated human T cells in the absence of any significant effect on (IFN)-gamma, lymphotoxin or IL-2, suggesting a modulatory effect of TGF-beta 2 on the interferon Th1/Th2) balance of immune responses. The inhibitory effect of TGF-beta on IFN-gamma production by unfractionated peripheral blood mononuclear cells is likely to reflect the blunting of natural killer cell activation by TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386318     DOI: 10.1002/eji.1830220833

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.

Authors:  Chun Geun Lee; Hye-Ryun Kang; Robert J Homer; Geoffrey Chupp; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2006-07

2.  Laminin α1 is a genetic modifier of TGF-β1-stimulated pulmonary fibrosis.

Authors:  Chang-Min Lee; Soo Jung Cho; Won-Kyung Cho; Jin Wook Park; Jae-Hyun Lee; Augustine M Choi; Ivan O Rosas; Ming Zheng; Gary Peltz; Chun Geun Lee; Jack A Elias
Journal:  JCI Insight       Date:  2018-09-20

Review 3.  Shared signaling systems in myeloid cell-mediated muscle regeneration.

Authors:  James G Tidball; Kenneth Dorshkind; Michelle Wehling-Henricks
Journal:  Development       Date:  2014-03       Impact factor: 6.868

4.  Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.

Authors:  E Bohn; E Schmitt; C Bielfeldt; A Noll; R Schulte; I B Autenrieth
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Inhibitory RNA molecules in immunotherapy for cancer.

Authors:  Chih-Ping Mao; T-C Wu
Journal:  Methods Mol Biol       Date:  2010

Review 6.  The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

Authors:  D A Horwitz; C O Jacob
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Inhibitory effects of transforming growth factor-beta (TGF-beta) on certain functions of intraepithelial lymphocytes.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

8.  Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells.

Authors:  A Magnan; I Frachon; B Rain; M Peuchmaur; G Monti; B Lenot; M Fattal; G Simonneau; P Galanaud; D Emilie
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

9.  Induction of cytokines and anti-cytokine autoantibodies in cerebrospinal fluid (CSF) during experimental bacterial meningitis.

Authors:  M Bakhiet; M Mustafa; J Zhu; R Harris; L Lindquist; H Link; A Diab
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

10.  Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures.

Authors:  Y Zhang; M Cosyns; M J Levin; A R Hayward
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.